Status:
ACTIVE_NOT_RECRUITING
Feasibility of Delivering VergeRx at FQHCs
Lead Sponsor:
University of Virginia
Conditions:
Tobacco Use Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cigarette smoking in the U.S. is highest among low income and Medicaid insured adults, and unfortunately, low-income smokers are even less likely to attempt to quit, less likely to use evidence-based ...
Detailed Description
Cigarette smoking in the U.S. is highest among low income and Medicaid insured adults, and unfortunately, low-income smokers are even less likely to attempt to quit, less likely to use evidence-based ...
Eligibility Criteria
Inclusion
- patient at participating Federally Qualified Health Center
- ≥18 years of age
- able to read, speak, and understand English
- report smoking ≥5 cigarettes per day for the past 6 months
- own a cell phone
- be willing and able to use NRT in the form of patch or lozenge
- not be pregnant or planning to be pregnant in the next 6 months
Exclusion
- have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)
Key Trial Info
Start Date :
September 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06161675
Start Date
September 23 2024
End Date
July 1 2026
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia
Charlottesville, Virginia, United States, 22903